Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Bristol-Myers Squibb Pharma Eeig

02 4Bristol-Myers Squibb Sa

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab; Relatlimab (Combination drug known as Opdualag)

Brand Name : Opdualag

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 240mg;80mg

Packaging :

Approval Date : 15/09/2022

Application Number : 20210913000057

Regulatory Info : Approved

Registration Country : Sweden

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 10mg/ml

Packaging :

Approval Date : 19/06/2015

Application Number : 20141009000029

Regulatory Info : Approved

Registration Country : Sweden

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Injectable Solution

Dosage Strength : 600mg

Packaging :

Approval Date : 26/05/2025

Application Number : 20240607000049

Regulatory Info : Approved

Registration Country : Sweden

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Nivolumab Bms

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 10mg/ml

Packaging :

Approval Date : 20/07/2015

Application Number : 20141009000036

Regulatory Info : Deregistered

Registration Country : Sweden

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 40mg/4ml

Packaging :

Approval Date : 30/11/2015

Application Number : 65660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/10ml

Packaging :

Approval Date : 30/11/2015

Application Number : 65660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 240mg/24ml

Packaging :

Approval Date : 30/11/2015

Application Number : 65660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 120mg/12ml

Packaging :

Approval Date : 30/11/2015

Application Number : 65660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 10MG

Packaging :

Approval Date : 2021-07-01

Application Number : 1151014001IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 10MG

Packaging :

Approval Date : 2019-11-12

Application Number : 1151014002IP

Regulatory Info : Authorized

Registration Country : Spain

blank